SEC Form 4 · accession 0001783108-26-000022
Hinge Health, Inc. · HNGE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Pursley
Officer — President
Period of report
Jun 22, 2026
Accepted (ET)
Jun 23, 2026 · 4:52 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001673743
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF2 | Jun 22, 2026 | S | 21,935 | $68.9271 | D | 751,962 | D | |
| Class A Common StockF3 | Jun 22, 2026 | S | 8,507 | $69.8247 | D | 743,455 | D | |
| Class A Common StockF4 | Jun 22, 2026 | S | 2,558 | $70.89 | D | 740,897 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 13, 2025.
- F2Represents the weighted average sale price. The lowest price at which shares were sold was $68.35 and the highest price at which shares were sold was $69.34. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
- F3Represents the weighted average sale price. The lowest price at which shares were sold was $69.35 and the highest price at which shares were sold was $70.345. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
- F4Represents the weighted average sale price. The lowest price at which shares were sold was $70.36 and the highest price at which shares were sold was $71.34. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.